Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: An EORTC ocular oncology group study

British Journal of Ophthalmology

Volumn 85, Issue 10, 2001, Pages 1208-1212

  Pe'er, J ^a   Stefani, F H ^b   Seregard, S ^c   Kivela, T ^d   Lommatzsch, P ^e   Prause, J U ^f   Sobottka, B ^g   Damato, B ^h   Chowers, I ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c ST ERIK S EYE HOSPITAL   (Sweden)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g UNIVERSITY OF TÜBINGEN   (Germany)

^h ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KI 67; MONOCLONAL ANTIBODY PC 10; RUTHENIUM 106; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CENTER; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL PROLIFERATION; CHOROID MELANOMA; CILIARY BODY TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; ENUCLEATION; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; NEOVASCULAR GLAUCOMA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UVEA MELANOMA;

ANALYSIS OF VARIANCE; ANTIGENS, NUCLEAR; BRACHYTHERAPY; CELL DIVISION; CHOROID NEOPLASMS; CILIARY BODY; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; RUTHENIUM RADIOISOTOPES; STAINING AND LABELING; STATISTICS, NONPARAMETRIC; UVEAL NEOPLASMS;

EID: 0034810530     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.85.10.1208     Document Type: Article

References (25)

1. Malignant melanoma of the choroid treated with radioactive applicators
2. 106Rh beta-ray applicators
3. The treatment of ophthalmic tumors with low-energy sources
4. Proton beam irradiation: An alternative to enucleation for intraocular melanomas
5. Helium ion therapy for choroidal melanoma
6. Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma
7. Stereotactic radiosurgery of large uveal melanomas with the gamma-knife
8. Histopathological changes in malignant melanomas of the choroid after cobalt plaque therapy
9. 106Rh) of choroidal melanomas: 20 years' experience
10. Histopathology of uveal melanomas treated with charged particle radiation
11. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings
12. Histopathology of proton beam-irradiated vs. enucleated uveal melanomas
13. Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma
14. Histopathologic findings in large uveal melanomas after brachytherapy with iodine 125 ophthalmic plaque
15. Histopathologic changes following irradiation for uveal tract melanoma
16. Histopathologic study of eyes after iodine 125 episcleral plaque irradiation for uveal melanoma
17. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma
18. A histologic study (including DNMA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques
19. Tumor cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma
20. Effects of proton beam irradiation on uveal melanomas: A comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas
21. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma
22. Standardized echography: Basic principles, clinical applications, and results
23. Analysis of radiation failure after uveal melanoma brachytherapy
24. Flow cytometry of uveal melanomas
25. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma